219 related articles for article (PubMed ID: 28371532)
21. Metabolic syndrome is associated with an increased risk of psoriasis: A nationwide population-based study.
Kim HN; Han K; Park YG; Lee JH
Metabolism; 2019 Oct; 99():19-24. PubMed ID: 31279740
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome and psoriatic arthritis among patients with psoriasis vulgaris: Quality of life and prevalence.
Souza CS; de Castro CCS; Carneiro FRO; Pinto JMN; Fabricio LHZ; Azulay-Abulafia L; Romiti R; Cestari TF; Suzuki CE; Biegun PM; Guedes LS; Oyafuso LKM
J Dermatol; 2019 Jan; 46(1):3-10. PubMed ID: 30474868
[TBL] [Abstract][Full Text] [Related]
23. Metabolic syndrome in Spanish patients with psoriasis needing systemic therapy: Prevalence and association with cardiovascular disease in PSO-RISK, a cross-sectional study.
Belinchón I; Vanaclocha F; de la Cueva-Dobao P; Coto-Segura P; Labandeira J; Herranz P; Taberner R; Juliá B; Cea-Calvo L; Puig L
J Dermatolog Treat; 2015; 26(4):318-25. PubMed ID: 25362972
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of serum uric acid levels in psoriasis vulgaris.
Yilmaz E; Tamer E; Artüz F; Külcü Çakmak S; Köktürk F
Turk J Med Sci; 2017 Apr; 47(2):531-534. PubMed ID: 28425242
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006.
Love TJ; Qureshi AA; Karlson EW; Gelfand JM; Choi HK
Arch Dermatol; 2011 Apr; 147(4):419-24. PubMed ID: 21173301
[TBL] [Abstract][Full Text] [Related]
26. Facial involvement in Indian psoriatic patients and its association with disease severity and metabolic syndrome: A cross-sectional study.
Ranugha PSS; Bishnoi P; Chandrashekar L
Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):522-527. PubMed ID: 31317874
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular Risk Factors and Carotid Intima-Media Thickness in a Colombian Population With Psoriasis.
Argote A; Mora-Hernández O; Milena Aponte L; Barrera-Chaparro DI; Muñoz-Ruiz LM; Giraldo-Mordecay L; Camargo D
Actas Dermosifiliogr; 2017 Oct; 108(8):738-745. PubMed ID: 28662815
[TBL] [Abstract][Full Text] [Related]
28. Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome.
Barrea L; Macchia PE; Di Somma C; Napolitano M; Balato A; Falco A; Savanelli MC; Balato N; Colao A; Savastano S
J Transl Med; 2016 May; 14(1):130. PubMed ID: 27165166
[TBL] [Abstract][Full Text] [Related]
29. High burden of the metabolic syndrome and its component disorders in South Africans with psoriasis.
Goolam Mahyoodeen N; Crowther NJ; Snyman T; Pillay L; Tikly M
Int J Dermatol; 2019 May; 58(5):557-562. PubMed ID: 30565666
[TBL] [Abstract][Full Text] [Related]
30. Association Between Pediatric Psoriasis and Waist-to-Height Ratio in the Absence of Obesity: A Multicenter Australian Study.
Lee A; Smith SD; Hong E; Garnett S; Fischer G
JAMA Dermatol; 2016 Dec; 152(12):1314-1319. PubMed ID: 27681388
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of metabolic syndrome in patients with psoriasis.
Nisa N; Qazi MA
Indian J Dermatol Venereol Leprol; 2010; 76(6):662-5. PubMed ID: 21079309
[TBL] [Abstract][Full Text] [Related]
32. The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.
Xu X; Su L; Gao Y; Ding Y
PLoS One; 2017; 12(1):e0169952. PubMed ID: 28099469
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of Metabolic Syndrome Among Patients with Psoriasis Treated with TNF Inhibitors and the Effects of Anti-TNF Therapy on Their Lipid Profile: A Prospective Cohort Study.
Botelho KP; Pontes MAA; Rodrigues CEM; Freitas MVC
Metab Syndr Relat Disord; 2020 Apr; 18(3):154-160. PubMed ID: 31928509
[No Abstract] [Full Text] [Related]
34. Metabolic syndrome in untreated patients with psoriasis: case-control study.
Damevska K; Neloska L; Gocev G; Mihova M
J Dtsch Dermatol Ges; 2013 Dec; 11(12):1169-75. PubMed ID: 24267013
[TBL] [Abstract][Full Text] [Related]
35. Comorbidities and cardiovascular risk factors in patients with psoriasis.
Baeta IG; Bittencourt FV; Gontijo B; Goulart EM
An Bras Dermatol; 2014; 89(5):735-44. PubMed ID: 25184912
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of metabolic syndrome in Montenegrin patients with psoriasis.
Ražnatović-Đurović M; Janković J; Janković S
Vojnosanit Pregl; 2016 Nov; 73(11):1016-21. PubMed ID: 29328640
[TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome and subclinical carotid atherosclerosis among Chinese elderly people living in a rural community.
Yan Z; Liang Y; Jiang H; Cai C; Sun B; Qiu C
Metab Syndr Relat Disord; 2014 Jun; 12(5):269-76. PubMed ID: 24588080
[TBL] [Abstract][Full Text] [Related]
38. Metabolic syndrome in patients with psoriatic disease.
Gelfand JM; Yeung H
J Rheumatol Suppl; 2012 Jul; 89():24-8. PubMed ID: 22751586
[TBL] [Abstract][Full Text] [Related]
39. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies.
Armstrong AW; Harskamp CT; Armstrong EJ
J Am Acad Dermatol; 2013 Apr; 68(4):654-662. PubMed ID: 23360868
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of metabolic syndrome in patients with psoriasis at Mostar Clinical Hospital.
Topić I; Simić D
Acta Clin Croat; 2013 Mar; 52(1):53-8. PubMed ID: 23837273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
